EUDA Health Holdings Limited
NASDAQ:EUDAMedical - Care Facilities
+$2.20 today
- Market cap
- $53.00M
- Beta
- 0.59
- P/E (TTM)
- -7.9
- EPS (TTM)
- -$1.79
Volume 0.04M
Average 0.02M
EUDA Gross Profit
Revenue minus cost of revenue: what remains to cover operating expenses after paying for what was sold.
EUDA Health Holdings LimitedNASDAQ: EUDA
Gross Profit · Q2 FY2026 · quarter ended Jun 2026
Gross profit grows, but more slowly than its trailing trend
Q2 FY2026 gross profit of $640.94K rose 53.5% year over year, behind the +363.3% change in trailing-twelve-month gross profit. Sequentially, it rose 0.0% from the prior quarter. Over 3 fiscal years it compounded at +51.0% a year.
Context
- Gross profit amounted to 43.9% of revenue in FY2025, up 24.9 pp from a year earlier.
- Gross profit increased in 1 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from +53.5% toward the trailing-twelve-month pace of +363.3%.
Sources:Income StatementText generated from reported figures; not investment advice.
Gross Profit history
USD · from the income statement
- Latest · FY2025
- 2.99M USD
- Year-over-year change
- +292.7%
- 4-year CAGR
- +24.4%
| Period | Period end | Gross Profit | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 2.99M | +292.7% |
| FY2024 | 2024-12-31 | 762.16K | -9.5% |
| FY2023 | 2023-12-31 | 842.08K | -3.2% |
| FY2022 | 2022-12-31 | 870K | -30.4% |
| FY2021 | 2021-12-31 | 1.25M | — |
Gross Profit vs competitors
How EUDA compares with its peers on the latest reported figures
- Peers report in different currencies, so gross profit is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +363.3% is the highest of 8, against a peer median of -14.6%.
- Gross profit amounts to 44.0% of revenue for EUDA, versus a peer median of 74.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $118M USD | +1.9% | +4.4% | 49.7% | |
| LTM Mar 2026 | $43.7M USD | -14.6% | +7.9% | 97.0% | |
| LTM Mar 2026 | $42.41M USD | -0.1% | -3.0% | 40.3% | |
| LTM Mar 2026 | $7.85M USD | +44.8% | +95.3% | 51.2% | |
| LTM Jun 2026 | $5.35M USD | +363.3% | +51.0% | 44.0% | |
| LTM Mar 2026 | $0 USD | -100.0% | — | — | |
| LTM Mar 2026 | -CA$4.19M CAD | -2219.9% | — | 2522.4% | |
| LTM Mar 2026 | -$22.33M USD | -82.6% | — | 11754.7% | |
| Peer median (excluding EUDA) | — | -14.6% | +6.1% | 74.1% | |
Competitors are the stored peer set for EUDA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 4.56M | 3.76M | 3.71M | 4.01M | 6.82M |
| Cost of Revenue | 3.31M | 2.89M | 2.86M | 3.25M | 3.83M |
| Gross Profit | 1.25M | 870K | 842.08K | 762.16K | 2.99M |
| Gross Margin | 27.4% | 23.1% | 22.7% | 19.0% | 43.9% |
| Research & Development | 129.27K | 17.21K | 0 | 0 | 249 |
| Selling, General & Admin | 1.81M | 6.75M | 4.8M | 3.34M | 5.43M |
| Operating Expenses | 1.81M | 13.09M | 4.8M | 18.1M | 5.43M |
| Depreciation & Amortization | 264.1K | 172.02K | 119.35K | 173.22K | 406.48K |
| EBITDA | 1.34M | (24.64M) | (8.29M) | (17.42M) | (2.09M) |
| EBITDA Margin | 29.4% | -654.6% | -223.7% | -434.4% | -30.7% |
| Operating Income | (559.99K) | (5.72M) | (3.96M) | (17.34M) | (2.44M) |
| Operating Margin | -12.3% | -151.9% | -106.9% | -432.2% | -35.8% |
| Interest Income | 1.92M | 0 | 0 | 0 | 0 |
| Interest Expense | 127.13K | 93.78K | 23.23K | 44.89K | 228.62K |
| Other Income / Expenses | 2.23M | (19.21M) | (4.47M) | (307.38K) | (285.26K) |
| Income Before Tax | 1.67M | (24.93M) | (8.43M) | (17.64M) | (2.73M) |
| Pre-Tax Margin | 36.6% | -662.3% | -227.6% | -439.8% | -40.0% |
| Income Tax Expense | 46.49K | (20.79K) | 0 | (4.38K) | 41.94K |
| Net Income | 864.83K | (24.88M) | (10.04M) | (15.36M) | (2.77M) |
| Net Margin | 19.0% | -661.1% | -270.9% | -382.9% | -40.7% |
| EPS (Basic) | 1.87 | (41.40) | (8.80) | (9.40) | (1.49) |
| EPS (Diluted) | 1.87 | (41.40) | (8.80) | (9.40) | (1.49) |
| Weighted Avg Shares | 462.67K | 601.48K | 1.15M | 1.62M | 1.86M |
| Weighted Avg Shares (Diluted) | 462.67K | 601.48K | 1.15M | 1.62M | 1.86M |
EUDA Health Holdings Limited
NASDAQ:EUDA
Intrinsic Alpha fair value
Locked
Current Price
$17.70
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.